. The company’s pipeline consists of 4 scientific-stage therapies. Its most Innovative drug candidate is ROS1 inhibitor taletrectinib for dealing with lung most cancers. Nuvation is completing two phase two pivotal experiments on taletrectinib. Do you have to invest in penny stocks? Focusing your whole portfolio on penny stocks https://financefeeds.com/bitcoin-could-hit-300k-by-2030-says-ark-invest/